Clinical resources

Infection testing: a clinical overview

Clinical relevance, typical presentation and testing considerations for the infection areas where molecular testing is commonly used.

General medical information for education only, not medical advice. For InnovexLab’s panels and their targets, see Panels. This page is for education and does not replace advice from a clinician.

Infection areas

Urinary tract infection

Clinical relevance
Among the most frequent infections in long-term care and outpatient practice, and account for a large share of antibiotic prescribing.
Typical presentation
Dysuria, frequency, urgency, suprapubic pain, flank pain or costovertebral-angle tenderness, fever or rigors without another source. In catheterized patients: fever, rigors, flank pain or new hematuria.
Testing considerations
Asymptomatic bacteriuria is common in older adults and catheterized patients; guidelines advise against screening for or treating it outside specific situations such as pregnancy and urologic procedures. Test symptomatic patients.

Wound infection

Clinical relevance
Chronic wounds are colonized by many organisms; infection delays healing and can progress to cellulitis or osteomyelitis, particularly in patients with diabetes or vascular disease.
Typical presentation
Spreading erythema, warmth, swelling, purulence, increasing pain, malodor, friable granulation tissue or a stalled wound.
Testing considerations
Infection is a clinical diagnosis; detection of organisms in a chronic wound does not by itself indicate infection. Collect after cleansing and debridement, from viable tissue where possible.

Respiratory infection

Clinical relevance
Respiratory viruses and bacteria spread readily in congregate settings, where identifying the cause guides isolation, cohorting and antiviral or antibiotic decisions.
Typical presentation
Cough, fever, sore throat, rhinorrhea, dyspnea or new oxygen requirement; clusters of cases on a unit.
Testing considerations
A viral result can support withholding antibiotics. Bacteria detected in upper-airway specimens may reflect colonization.

Gastrointestinal infection

Clinical relevance
Infectious diarrhea can spread readily through a facility; identifying the pathogen guides infection-control measures and treatment.
Typical presentation
Acute diarrhea, particularly with fever, blood or mucus, abdominal pain or vomiting; clusters of cases.
Testing considerations
Test unformed stool from patients with clinically significant diarrhea not explained by laxatives or other causes. Multiplex detection can identify carriage (for example of Clostridioides difficile) as well as disease.

Onychomycosis

Clinical relevance
Nail dystrophy has many causes, including psoriasis and trauma; confirming a fungal cause supports appropriate antifungal therapy.
Typical presentation
Thickened, discolored, brittle or onycholytic nails.
Testing considerations
Laboratory confirmation is recommended before systemic antifungal treatment. Dermatophytes, non-dermatophyte molds and yeasts differ in treatment response.

Vaginitis and vaginosis

Clinical relevance
Bacterial vaginosis, vulvovaginal candidiasis and trichomoniasis present similarly and frequently coexist.
Typical presentation
Abnormal discharge, odor, itching, irritation or dysuria.
Testing considerations
Distinguishing the causes supports targeted therapy; some organisms are part of the normal vaginal flora.

Sexually transmitted infections

Clinical relevance
Many sexually transmitted infections are asymptomatic; untreated infection can cause pelvic inflammatory disease, infertility and onward transmission.
Typical presentation
Urethral or vaginal discharge, dysuria, genital ulcers, pelvic pain; or recommended screening without symptoms.
Testing considerations
Follow current screening recommendations; partner management and public-health reporting apply to several infections.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.